ENDOMETRIAL CANCER STAGE III

This adverse event was reported 79 times

These drugs are most commonly taken by patients reporting ENDOMETRIAL CANCER STAGE III:

# Drug Count
0 LEVOTHYROXINE SODIUM 18
1 ANASTROZOLE 16
2 ENALAPRIL 16
3 LEVOTHYROXINE SODIUM ANHYDROUS 16
4 PANTOPRAZOLE SODIUM 16
5 ANASTROZOLE TABLETS 15
6 BEVACIZUMAB 15
7 DOXORUBICIN 15
8 LETROZOLE 15
9 LETROZOLE TABLETS 15
See all common drugs associated with ENDOMETRIAL CANCER STAGE III

ENDOMETRIAL CANCER STAGE III is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CALCIUM CARBONATE ANTACID 1 0.0130
1 TOREMIFENE CITRATE 2 0.0046
2 ANASTROZOLE TABLETS 15 0.0007
3 TESTOSTERONE ENANTHATE 1 0.0006
4 ANASTROZOLE 16 0.0004
5 DOXORUBICIN HYDROCHLORIDE 14 0.0004
6 DOSTARLIMAB 1 0.0004
7 BARICITINIB 1 0.0003
8 LETROZOLE TABLETS 15 0.0003
9 ENALAPRIL 16 0.0003
See all drugs enriched for association with ENDOMETRIAL CANCER STAGE III